Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, Pittsburgh, PA, USA.
Abound Bio, Pittsburgh, PA, USA.
STAR Protoc. 2021 Sep 17;2(3):100617. doi: 10.1016/j.xpro.2021.100617. Epub 2021 May 29.
This protocol is a comprehensive guide to phage display-based selection of virus neutralizing V antibody domains. It details three optimized parts including (1) construction of a large-sized (theoretically > 10) naïve human antibody heavy chain domain library, (2) SARS-CoV-2 antigen expression and stable cell line construction, and (3) library panning for selection of SARS-CoV-2-specific antibody domains. Using this protocol, we identified a high-affinity neutralizing human V antibody domain, V ab8, which exhibits high prophylactic and therapeutic efficacy. For complete details on the use and execution of this protocol, please refer to Li et al. (2020).
本方案是基于噬菌体展示技术筛选病毒中和 V 抗体结构域的全面指南。它详细介绍了三个优化部分,包括(1)构建大型(理论上> 10)的原始人抗体重链结构域文库,(2)SARS-CoV-2 抗原表达和稳定细胞系构建,以及(3)文库淘选以筛选 SARS-CoV-2 特异性抗体结构域。使用本方案,我们鉴定了一种高亲和力中和人 V 抗体结构域 V ab8,其具有高的预防和治疗功效。有关本方案使用和执行的完整详细信息,请参阅 Li 等人。(2020)。